420 PROSTVAC in combination with nivolumab enhanced immune cell infiltration in prostate cancer

• Ravi Madan,
• Jennifer Marte,
• James Gulley,
• Antonios Papanicolau-Sengos,
• Fatima Karzai,
• Amy Hankin,
• Houssein Abdul Sater,
• William Dahut,
• Shania Bailey,
• Wiem Lassoued,
• Nikki Williams,
• Michell Manu,
• Peter Pinto

Affiliations

Ravi Madan

Aff2 grid.48336.3a0000000419368075National Cancer Institute Bethesda MD USA

Jennifer Marte

Aff3 National Cancer Institute/Genitourinary Malignancies Branch Bethesda MD USA

James Gulley

NIH, Bethesda, MD, USA

Antonios Papanicolau-Sengos

Aff4 OmniSeq Inc. 14203 Buffalo NY USA

Fatima Karzai

Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA

Amy Hankin

Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA

Houssein Abdul Sater

13National Cancer Institute, Bethesda, MD, USA

William Dahut

Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA

Shania Bailey

1NIH, Bethesda, MD, USA

Wiem Lassoued

2NCI, Frederick, MD, USA

Nikki Williams

1NIH, Bethesda, MD, USA

Michell Manu

1NIH, Bethesda, MD, USA

Peter Pinto

1NIH, Bethesda, MD, USA